PMID: 11323111Apr 27, 2001Paper

Striatal dopaminergic metabolism is increased by deep brain stimulation of the subthalamic nucleus in 6-hydroxydopamine lesioned rats

Neuroscience Letters
Wassilios MeissnerAndreas Kupsch

Abstract

Deep brain stimulation of the subthalamic nucleus is an established therapeutic strategy for patients with Parkinson's disease. Although the exact mechanisms of action remain unknown, it is noteworthy that dopaminergic medication can be markedly reduced after neurostimulation of the subthalamic nucleus. Previously, we have shown that deep brain stimulation of the subthalamic nucleus is followed by an increase of striatal extracellular dopamine metabolites in naive rats. In the present study we examined the effects of deep brain stimulation on striatal monoamine metabolism in the intrastriatal 6-hydroxydopamine rat model of Parkinson's disease. Deep brain stimulation of the subthalamic nucleus was followed by a delayed increase of extracellular 3,4-dihydroxyphenylacetic and homovanillic whereas dopamine levels were unchanged in stimulated rats and controls. Our results indicate that deep brain stimulation of the subthalamic nucleus affects significantly striatal dopaminergic metabolism in 6-hydroxydopamine lesioned rats.

References

May 1, 1990·Pharmacology, Biochemistry, and Behavior·K E SabolC R Freed
Jun 1, 1995·Neurodegeneration : a Journal for Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration·A JafferJ J Taljaard
Nov 11, 1999·Current Opinion in Neurology·P KrackG Deuschl
Feb 17, 2000·The New England Journal of Medicine·P R SchuurmanJ D Speelman

❮ Previous
Next ❯

Citations

Jan 9, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Ruediger HilkerWolf-Dieter Heiss
Jul 29, 2005·Journal of Neural Transmission·I K GoerendtD J Brooks
Nov 7, 2003·Neurochemistry International·Wassilios MeissnerAndreas Kupsch
Jan 15, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Eduardo A SchilmanDaphna Joel
Apr 1, 2009·Neuromodulation : Journal of the International Neuromodulation Society·Kendall H LeeZang-Hee Cho
Jul 1, 2010·Neuromodulation : Journal of the International Neuromodulation Society·Daniel Harnack, Andreas Kupsch
Sep 9, 2004·Journal of Neurosurgery·Kendall H LeeUhnoh Kim
Nov 18, 2015·Journal of Neural Transmission·Thomas MüllerManfred Gerlach
Feb 17, 2015·Neuroscience and Biobehavioral Reviews·Claudio Da CunhaCharles D Blaha
Nov 24, 2007·Neuroscience and Biobehavioral Reviews·Jing-Yu ChangDonald J Woodward
Aug 25, 2015·Progress in Neurobiology·Kaviraja Udupa, Robert Chen
Feb 9, 2005·Journal of Neuroscience Methods·Jan GimsaUlrike Gimsa
Jan 24, 2007·The European Journal of Neuroscience·Jeannette HenningUlrike Gimsa
Jan 26, 2011·Journal of Clinical Neurology·Rahul S ShahKendall H Lee
Nov 16, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·D Luke Fischer, Caryl E Sortwell
Jan 11, 2008·Neuroreport·Rene ReeseWassilios Meissner
Apr 3, 2020·Expert Opinion on Drug Metabolism & Toxicology·Thomas Müller
Sep 22, 2018·International Journal of Molecular Sciences·Han-Fang WuHui-Ching Lin
Aug 2, 2011·Basal Ganglia·Reka Natarajan, Bryan K Yamamoto

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.